Fundz

Who to call at NeuroKaire, and when

Fundz watches for the moments NeuroKaire starts buying, and tells you who to reach.

  • An alert the day NeuroKaire raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeuroKaire, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchNeuroKaire Achieves CLIA Certification for its Pharmacogenetic Assay in Psychiatry and Neurology.

Nov 21, 2024
New JerseyBiotechnologyHealth CareMedicalTherapeutics

Product Description

NeuroKaire announced that its laboratory in Kearny, NJ has received CLIA certification to perform high-complexity clinical testing, with its first offering being a pharmacogenetic assay focused on psychiatric and neurological drugs, enabling personalized medication plans.

Company Information

Company

NeuroKaire

Location

New Jersey, United States

About

NeuroKaire is developing personalized medicine solutions to optimize treatment for psychiatric and neurological diseases. The company's proprietary technology assists physicians in identifying the best treatment for their patients by utilizing unique neurological biomarkers. This approach aims to improve drug therapy selection, leading to faster treatment with fewer side effects. Additionally, NeuroKaire supports pharmaceutical companies in implementing precision medicine throughout drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeuroKaire ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Stephanie hidden

hidden

Issar hidden

hidden

Orit hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NeuroKaire's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

NeuroKaire shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.